Immune boosting benefits of tuberculosis vaccine seen in inf
A randomized controlled trial involving 130 infants has shown how the BCG vaccine, developed to prevent the risk of tuberculosis, can produce a "trained immunity response" lasting more than 14 months after the vaccine is administered. Those randomized to be vaccinated received their jab within 10 days of birth. The off-target effects of the BCG vaccine against a range of viruses are explained in part by the reprogramming of how your genes work in the monocyte due to environmental and behavioral factors, researchers said. The reprogramming of monocytes, a cell previously thought to have no capacity for memory, leads to trained immunity.